Emerging data from trials exploring mixing different types of vaccines demonstrate the practice is safe and could boost immunity.
US declares support for waiver of COVID-19 vaccines patents
In a historic and surprise move, this week the US declared its support for a patent waiver on COVID-19 vaccines.
Pseudoviruses help determine the success of COVID-19 vaccines and antibody therapies
Assays using pseudoviruses have been indispensable in our efforts to halt the current pandemic.
The first COVID-19 vaccines are here, but challenges remain
Whilst vaccines against COVID-19 show there is light at the end of the tunnel, three main challenges still need to be addressed.
Potential vaccines against COVID-19 on trial in UK and Germany
The two countries, in separate studies, begin human trials of potential vaccines against COVID-19.
Hydrogel vaccines could spell the end of booster shots and vaccine inequity
A hydrogel delivery system boosts single-dose efficacy and provides a potential tool to fight future pandemics and vaccine inequity.
Using nanomaterials as antivirals in the fight against COVID-19
Scientists are investigating how fullerene nanomaterials can be used as antivirals against different variants of SARS-CoV-2 and other viruses.
Module labs are a polarizing plan for COVID-19 vaccine manufacturing in Africa
Without independent vaccine manufacturing in Africa, the social and economic costs of the pandemic will only be prolonged.
Waning immunity and COVID-19 boosters modeled in digital town
The debate around COVID-19 boosters is highly nuanced, but a new computational model could help better inform policy around such measures in an evolving pandemic.
Computer simulations pave the way for improved mRNA vaccines
Molecular dynamics offer ways to improve lipid-based therapeutic delivery systems.